Avidity Biosciences
RNA
#1831
Rank
โ‚ฌ9.24 B
Marketcap
61,38ย โ‚ฌ
Share price
-0.06%
Change (1 day)
70.15%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: โ‚ฌ9.24 Billion

As of December 2025 Avidity Biosciences has a market cap of โ‚ฌ9.24 Billion. This makes Avidity Biosciences the world's 1831th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ9.24 B167.91%
2024โ‚ฌ3.45 B432.59%
2023โ‚ฌ0.64 B-52.86%
2022โ‚ฌ1.37 B39.68%
2021โ‚ฌ0.98 B26.42%
2020โ‚ฌ0.77 B

End of Day market cap according to different sources

On Dec 4th, 2025 the market cap of Avidity Biosciences was reported to be:

โ‚ฌ9.24 Billion
by Nasdaq info icon info icon
โ‚ฌ9.24 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
PTC Therapeutics
PTCT
โ‚ฌ5.36 B-42.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
โ‚ฌ0.7 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚ฌ2.05 B-77.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚ฌ2.43 B-73.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
โ‚ฌ0.10 B-98.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
โ‚ฌ9.37 B 1.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ125.37 B 1,255.58%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ84.11 B 809.53%๐Ÿ‡ฌ๐Ÿ‡ง UK